THPO and autoimmune thrombocytopenic purpura: Since the discovery of the role of thrombopoietin (TPO) in ITP several thrombopoietic drugs was tested (113), and in 2008 FDA approved two TPO receptor agonists for non-responsive ITP in adults: romiplostim and eltrombopag (114, 115).